ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 105 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $20,966,000 | -36.4% | 1,443,920 | -12.5% | 0.18% | -10.1% |
| Q2 2018 | $32,965,000 | +14.0% | 1,650,715 | 0.0% | 0.20% | -32.2% |
| Q1 2018 | $28,921,000 | -12.5% | 1,650,715 | +23.2% | 0.29% | -14.4% |
| Q4 2017 | $33,043,000 | -4.9% | 1,339,931 | -0.5% | 0.34% | -12.8% |
| Q3 2017 | $34,742,000 | -4.8% | 1,346,049 | 0.0% | 0.39% | -20.4% |
| Q2 2017 | $36,505,000 | +26.1% | 1,346,049 | +38.6% | 0.49% | +13.1% |
| Q1 2017 | $28,957,000 | – | 971,049 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,858,569 | $85,243,000 | 25.08% |
| Sofinnova Management VIII, L.L.C. | 1,539,480 | $45,907,000 | 24.21% |
| EcoR1 Capital, LLC | 673,100 | $20,072,000 | 5.07% |
| Cormorant Asset Management, LP | 800,000 | $23,856,000 | 3.46% |
| Perceptive Advisors | 1,260,847 | $37,598,000 | 2.14% |
| NEXTHERA CAPITAL LP | 111,500 | $3,325,000 | 1.70% |
| Foresite Capital Management III, LLC | 140,000 | $4,175,000 | 1.60% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $5,964,000 | 1.41% |
| Rock Springs Capital Management LP | 675,000 | $20,129,000 | 1.16% |
| CAXTON CORP | 13,263 | $395,000 | 1.13% |